WaveCyte Biotechnologies is a biotechnology company leveraging our vast scientific and technical expertise to partner with other researchers to discover next generation of best-in-class biologics, with an emphasis on cell and gene therapy. WaveCyte’s platform technology combines a proprietary non-viral cell transfection process with automation for high scalability, predictability and reproducibility making non-viral cell engineering easier and faster.